Where does Gfbiochemicals IP Assets B.V. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Gfbiochemicals IP Assets B.V. ranks #28,851 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Gfbiochemicals IP Assets B.V. hold?

Gfbiochemicals IP Assets B.V. holds 9 US utility patents granted between 2019 and 2025, spanning 6 technology areas.

What is Gfbiochemicals IP Assets B.V.'s Innovation Score?

Gfbiochemicals IP Assets B.V. has an Innovation Score of 26.9 out of 100 (22nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Gfbiochemicals IP Assets B.V. focus on?

Gfbiochemicals IP Assets B.V.'s top technology area is C07C (Acyclic OR Carbocyclic Compounds) with 7 patents. Grants appear in 6 CPC subclasses total.

Is Gfbiochemicals IP Assets B.V.'s patent grant rate increasing or decreasing?

Gfbiochemicals IP Assets B.V.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Gfbiochemicals IP Assets B.V.'s patents?

Gfbiochemicals IP Assets B.V.'s patents average 17.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Gfbiochemicals IP Assets B.V. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Gfbiochemicals IP Assets B.V.

USPTO PatentsView assignee record - 9 granted patents across 6 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Gfbiochemicals ranks #28,851 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 6 technology areas.

#28,851
of 49,997 US assignees by volume: 22nd percentile
by Innovation Score (26.9/100): 17.1
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R28851 · Foreign Corporation #28,851 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #28,851/49,997
PHOTO-FINISH Genesense Technology
CPC-NARROW C07C · 6 areas
INNOV-THIN 26.9/100
CLAIMS-RICH 17.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Genesense Technology Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Gfbiochemicals IP… · this assignee

27
3D Lighting… · lowest

7

What this shows Gfbiochemicals's Innovation Score is 26.9/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Gfbiochemicals's grants concentrate

Gfbiochemicals IP Assets B.V. is a focused PatentsView assignee: 6 CPC subclasses with 77.8% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2021. By volume, Gfbiochemicals sits between Genesense Technology Inc. and Gianni Versace S.p.A..

Genesense Technol…

9
Gentherm Automoti…

9
Geomagical Labs

9
George TFE SCP

9
Gfpi

9
GI Innovation

9
GI Supply

9
Gianni Versace S…

9
Gfbiochemicals IP… ◀

9

What this shows Gfbiochemicals holds 9 patents at rank #28,821, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Gfbiochemicals

By rank, the assignees closest to #28,821 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Gfbiochemicals's primary technology class.

Gfbiochemicals's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Gfbiochemicals IP Assets B.V. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	4	44.4%
2020	3	33.3%
2021	1	11.1%
2025partial year	1	11.1%

Which technologies does Gfbiochemicals IP Assets B.V. patent most?

C07C - Acyclic OR Carbocyclic Compounds 7

B01D - Separation 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

C07D - Heterocyclic Compounds 2

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 2

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 2

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#28,851

of 49,997 tracked assignees

Innovation Score

26.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Gfbiochemicals IP Assets B.V.'s patent record in context - here's where to go next.

Gfbiochemicals IP Assets B.V.'s lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 77.8% of its portfolio - see every assignee active in that class. Explore C07C
Ranked #28,851 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Gfbiochemicals IP Assets B.V. against Genesense Technology Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.